Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2016 Supplemental Victimization Survey (SVS), 20422-20423 [2016-07961]
Download as PDF
20422
Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices
Controlled substance
Schedule
Phenmetrazine (1631) .................................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Glutethimide (2550) .....................................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................
Alphaprodine (9010) ....................................................................................................................................................................................
Anileridine (9020) ........................................................................................................................................................................................
Etorphine HCI (9059) ..................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Isomethadone (9226) ..................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Meperidine intermediate-A (9232) ...............................................................................................................................................................
Meperidine intermediate-B (9233) ...............................................................................................................................................................
Meperidine intermediate-C (9234) ...............................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Metopon (9260) ...........................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Dihydroetorphine (9334) ..............................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
Phenazocine (9715) ....................................................................................................................................................................................
Piminodine (9730) .......................................................................................................................................................................................
Racemethorphan (9732) ..............................................................................................................................................................................
Racemorphan (9733) ...................................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Tapentadol (9780) .......................................................................................................................................................................................
Bezitramide (9800) ......................................................................................................................................................................................
Moramide-intermediate (9802) ....................................................................................................................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Dated: March 29, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–07947 Filed 4–6–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
16:35 Apr 06, 2016
Jkt 238001
FOREIGN CLAIMS SETTLEMENT
COMMISSION
[F.C.S.C. Meeting and Hearing Notice No.
4–16]
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 503.25) and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice in
regard to the scheduling of open
meetings as follows:
Thursday, April 14, 2016
10:00 a.m.—Oral hearings on Objection
to Commission’s Proposed Decision
in Claim No. LIB–III–012.
11:30 a.m.—Issuance of Proposed
Decisions in claims against Iraq.
Status: Open.
All meetings are held at the Foreign
Claims Settlement Commission, 600 E
Street NW., Washington, DC. Requests
for information, or advance notices of
intention to observe an open meeting,
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
may be directed to: Patricia M. Hall,
Foreign Claims Settlement Commission,
600 E Street NW., Suite 6002,
Washington, DC 20579. Telephone:
(202) 616–6975.
Brian M. Simkin,
Chief Counsel.
[FR Doc. 2016–08019 Filed 4–5–16; 8:45 am]
BILLING CODE 4410–BA–P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0302]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested;
Reinstatement, With Change, of a
Previously Approved Collection for
Which Approval Has Expired: 2016
Supplemental Victimization Survey
(SVS)
Bureau of Justice Statistics,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
E:\FR\FM\07APN1.SGM
07APN1
Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 81 FR 6050, February 4,
2016, allowing for a 60 day comment
period.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until May 9, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Jennifer Truman or Rachel Morgan,
Statisticians, Bureau of Justice Statistics,
810 Seventh Street NW., Washington,
DC 20531 (email: Jennifer.Truman@
usdoj.gov; telephone: 202–514–5083;
email: Rachel.Morgan@usdoj.gov;
telephone: 202–616–1707). Written
comments and/or suggestions can also
be directed to the Office of Management
and Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington, DC 20530 or sent to OIRA_
submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
mstockstill on DSK4VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
16:35 Apr 06, 2016
Jkt 238001
permitting electronic submission of
responses.
Overview of this information
collection:
(1) Type of Information Collection:
Reinstatement of the Supplemental
Victimization Survey (SVS), with
changes, a previously approved
collection for which approval has
expired.
(2) Title of the Form/Collection: 2016
Supplemental Victimization Survey
(SVS)
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: The form number for the
questionnaire is SVS–1. The applicable
component within the Department of
Justice is the Bureau of Justice Statistics,
in the Office of Justice Programs.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Respondents will be persons
16 years or older living in households
located throughout the United States
sampled for the National Crime
Victimization Survey (NCVS). The SVS
will be conducted as a supplement to
the NCVS in all sample households for
a six (6) month period. The SVS is
primarily an effort to measure the
prevalence of stalking victimization
among persons, the types of stalking
victimization experienced, the
characteristics of stalking victims, the
nature and consequences of stalking
victimization, and patterns of reporting
to the police. BJS plans to publish this
information in reports and reference it
when responding to queries from the
U.S. Congress, Executive Office of the
President, the U.S. Supreme Court, state
officials, international organizations,
researchers, students, the media, and
others interested in criminal justices
statistics.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimate of the total
number of respondents is 111,960.
About 98.5% (110,280) will have no
stalking victimization and will complete
the short interview with an average
burden of four (4) minutes. Among the
1.5% of respondents (1,679) who
experience stalking victimization, the
time to ask the detailed questions
regarding the aspects of their stalking
victimization is estimated to take an
average of 12.25 minutes. Respondents
will be asked to respond to this survey
only once during the six month period.
The burden estimates are based on data
from the prior administration of the
SVS.
(6) An estimate of the total public
burden (in hours) associated with the
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
20423
collection: There are an estimated 8,055
total burden hours associated with this
collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405B,
Washington, DC 20530.
Dated: April 4, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–07961 Filed 4–6–16; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Modification of Consent Decree Under
the Clean Air Act
On March 30, 2016, the Department of
Justice lodged a proposed stipulation to
modify a Consent Decree with the
United States District Court for the
Eastern District of Wisconsin in the
lawsuit entitled United States v.
Wisconsin Public Service Corporation,
Civil Case No. 13–C–10 (E.D. Wis.).
The original Consent Decree resolved
alleged violations of the New Source
Review and Title V provisions of the
Clean Air Act (‘‘Act’’), 42 U.S.C. 7470–
92 and 7661a–7661f, at two coal-fired
power plants owned and operated by
Wisconsin Public Service Corp
(‘‘Defendant’’): the Weston plant located
in Marathon County, Wisconsin, and the
Pulliam plant located in Brown County,
Wisconsin. The proposed modifications
would: (1) Facilitate the Defendant’s
decision to convert a unit at the Weston
plant from burning coal to natural gas,
thereby reducing particulate matter
(‘‘PM’’) emissions such that the
operation of certain PM controls at that
unit is no longer necessary to achieve
the PM reductions secured by the
Decree; (2) replace a hydroelectric
environmental mitigation project that
was deemed unworkable with a new
land acquisition and restoration project
and an expansion of an existing wood
stove replacement program; and (3)
revise and update certain administrative
notice and certification requirements.
The publication of this notice opens
a period for public comment on the
proposed modifications to the Consent
Decree. Comments should be addressed
to the Assistant Attorney General,
Environment and Natural Resources
Division, and should refer to United
States v. Wisconsin Public Service
Corporation, Civil Case No. 13–C–10
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 81, Number 67 (Thursday, April 7, 2016)]
[Notices]
[Pages 20422-20423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07961]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1121-0302]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Reinstatement, With Change, of a Previously
Approved Collection for Which Approval Has Expired: 2016 Supplemental
Victimization Survey (SVS)
AGENCY: Bureau of Justice Statistics, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
[[Page 20423]]
SUMMARY: The Department of Justice (DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be submitting the following
information collection request to the Office of Management and Budget
(OMB) for review and approval in accordance with the Paperwork
Reduction Act of 1995. This proposed information collection was
previously published in the Federal Register at 81 FR 6050, February 4,
2016, allowing for a 60 day comment period.
DATES: Comments are encouraged and will be accepted for an additional
30 days until May 9, 2016.
FOR FURTHER INFORMATION CONTACT: If you have additional comments
especially on the estimated public burden or associated response time,
suggestions, or need a copy of the proposed information collection
instrument with instructions or additional information, please contact
Jennifer Truman or Rachel Morgan, Statisticians, Bureau of Justice
Statistics, 810 Seventh Street NW., Washington, DC 20531 (email:
Jennifer.Truman@usdoj.gov; telephone: 202-514-5083; email:
Rachel.Morgan@usdoj.gov; telephone: 202-616-1707). Written comments
and/or suggestions can also be directed to the Office of Management and
Budget, Office of Information and Regulatory Affairs, Attention
Department of Justice Desk Officer, Washington, DC 20530 or sent to
OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the Bureau of Justice
Statistics, including whether the information will have practical
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of this information collection:
(1) Type of Information Collection: Reinstatement of the
Supplemental Victimization Survey (SVS), with changes, a previously
approved collection for which approval has expired.
(2) Title of the Form/Collection: 2016 Supplemental Victimization
Survey (SVS)
(3) Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: The form number for
the questionnaire is SVS-1. The applicable component within the
Department of Justice is the Bureau of Justice Statistics, in the
Office of Justice Programs.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract: Respondents will be persons 16 years or older
living in households located throughout the United States sampled for
the National Crime Victimization Survey (NCVS). The SVS will be
conducted as a supplement to the NCVS in all sample households for a
six (6) month period. The SVS is primarily an effort to measure the
prevalence of stalking victimization among persons, the types of
stalking victimization experienced, the characteristics of stalking
victims, the nature and consequences of stalking victimization, and
patterns of reporting to the police. BJS plans to publish this
information in reports and reference it when responding to queries from
the U.S. Congress, Executive Office of the President, the U.S. Supreme
Court, state officials, international organizations, researchers,
students, the media, and others interested in criminal justices
statistics.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: An estimate of
the total number of respondents is 111,960. About 98.5% (110,280) will
have no stalking victimization and will complete the short interview
with an average burden of four (4) minutes. Among the 1.5% of
respondents (1,679) who experience stalking victimization, the time to
ask the detailed questions regarding the aspects of their stalking
victimization is estimated to take an average of 12.25 minutes.
Respondents will be asked to respond to this survey only once during
the six month period. The burden estimates are based on data from the
prior administration of the SVS.
(6) An estimate of the total public burden (in hours) associated
with the collection: There are an estimated 8,055 total burden hours
associated with this collection.
If additional information is required contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530.
Dated: April 4, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-07961 Filed 4-6-16; 8:45 am]
BILLING CODE 4410-18-P